
    
      This is a randomized, double-blinded, placebo-controlled, multicenter study to evaluate the
      clinical equivalence of the test formulation of Linaclotide (manufactured by Jiangsu Hansoh
      Pharmaceutical Co., Ltd.) compared to the marketed formulation LINZESSÂ® in patients with
      Chronic Idiopathic Constipation.
    
  